NCT02126384View on ClinicalTrials.gov

Identifocation the B Cell Subsets Responsible for Anti-pneumococcal Response

NACompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

November 18, 2014

Primary Completion Date

April 30, 2016

Study Completion Date

April 5, 2016

Conditions
Pneumococcal Diseases
Interventions
DRUG

pneumovax vaccination

vaccination

Trial Locations (1)

75015

Centre d'Investigation Clinique, hôpital Necker Enfants Malades, Paris

All Listed Sponsors
lead

Institut National de la Santé Et de la Recherche Médicale, France

OTHER_GOV

NCT02126384 - Identifocation the B Cell Subsets Responsible for Anti-pneumococcal Response | Biotech Hunter | Biotech Hunter